Clinical • Enrollment change • Trial completion date • Trial primary completion date • Combination therapy
|
EGFR (Epidermal growth factor receptor) • BRAF (B-raf proto-oncogene)
|
EGFR mutation
|
Keytruda (pembrolizumab) • Tagrisso (osimertinib) • gotistobart (BNT316)